Here you will find our latest press release.
For publications, please name the copyright as indicated in the pictures.

Current press release

DowDuPont and 'Baysanto' have taken the lead in new methods of genetic engineering

DowDuPont is ahead having filed around 50 international patent applications (at the WIPO in Geneva) for genome editing and plants, followed by 'Baysanto' with around 30 applications. The US company Cellectis (and its subsidiary Calyxt), in cooperation with Bayer, is registered as having filed more than 20 applications. Further applicants are Syngenta and BASF. So far, very few patents have been filed by traditional breeding companies. These are results of recent patent research evaluated by Testbiotech.

Dateianhänge:
AttachmentSize
PDF icon more CRISPR patents.pdf92.58 KB

Press contact

For inquiries or interviews, please contact Christoph Then.

  • Email: info[at]testbiotech.org (without brackets)
  • Phone: 0151 54638040

Would you like to be included in our press mailing list?
Please send us an e-mail with subject "Press mailing" to the e-mail address above.

Further press releases

02 May 2018
Untruthful assertions about new methods of genetic engineering
06 April 2018
Glyphosate resistant plants show a surprisingly high potential for uncontrolled environmental spread
14 March 2018
Legal revision of risks of genetically engineered soybeans is admissible in court
28 February 2018
No clear distinction between breeding and genetic engineering